BG25798A3 - A method of obtaining 6-mean opening bracket alfa-(amidine-and imidoilamine-alkanoilamine)-aracylamine mean closing bracket-penicylane acids - Google Patents

A method of obtaining 6-mean opening bracket alfa-(amidine-and imidoilamine-alkanoilamine)-aracylamine mean closing bracket-penicylane acids

Info

Publication number
BG25798A3
BG25798A3 BG7300024251A BG2425173A BG25798A3 BG 25798 A3 BG25798 A3 BG 25798A3 BG 7300024251 A BG7300024251 A BG 7300024251A BG 2425173 A BG2425173 A BG 2425173A BG 25798 A3 BG25798 A3 BG 25798A3
Authority
BG
Bulgaria
Prior art keywords
mean
bracket
penicylane
imidoilamine
aracylamine
Prior art date
Application number
BG7300024251A
Other languages
Bulgarian (bg)
Inventor
Hamanaka
Stam
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BG25798A3 publication Critical patent/BG25798A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG7300024251A 1972-08-02 1973-08-02 A method of obtaining 6-mean opening bracket alfa-(amidine-and imidoilamine-alkanoilamine)-aracylamine mean closing bracket-penicylane acids BG25798A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27706472A 1972-08-02 1972-08-02

Publications (1)

Publication Number Publication Date
BG25798A3 true BG25798A3 (en) 1978-12-12

Family

ID=23059254

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7300024251A BG25798A3 (en) 1972-08-02 1973-08-02 A method of obtaining 6-mean opening bracket alfa-(amidine-and imidoilamine-alkanoilamine)-aracylamine mean closing bracket-penicylane acids

Country Status (30)

Country Link
JP (1) JPS5318039B2 (en)
AR (1) AR206879A1 (en)
AT (1) AT327382B (en)
AU (1) AU472676B2 (en)
BE (1) BE803094A (en)
BG (1) BG25798A3 (en)
CA (1) CA1015355A (en)
CH (1) CH574447A5 (en)
CS (1) CS168459B2 (en)
DD (1) DD106849A5 (en)
DE (1) DE2338389A1 (en)
DK (1) DK137047B (en)
EG (1) EG10896A (en)
ES (1) ES417461A1 (en)
FI (1) FI56840C (en)
FR (1) FR2194415B1 (en)
GB (1) GB1418656A (en)
HU (1) HU167653B (en)
IE (1) IE37961B1 (en)
IL (1) IL42820A (en)
LU (1) LU68143A1 (en)
NL (1) NL7310696A (en)
NO (1) NO144831C (en)
PH (1) PH12770A (en)
PL (1) PL96500B1 (en)
RO (2) RO68719A2 (en)
SE (1) SE415977B (en)
SU (2) SU576944A3 (en)
YU (1) YU36966B (en)
ZA (1) ZA735236B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024130A (en) * 1975-03-31 1977-05-17 Pfizer Inc. Process for the manufacture of alkali metal salts of 6-[2-phenyl-2-(imidoylaminoalkanoylamino)acetamido]penicillanic acids
US4073780A (en) * 1976-06-03 1978-02-14 Pfizer Inc. 4-Pyridylformimidoylglycyl-D-phenylglycine

Also Published As

Publication number Publication date
SE415977B (en) 1980-11-17
RO63748A (en) 1979-01-15
DK137047C (en) 1978-08-07
DD106849A5 (en) 1974-07-05
HU167653B (en) 1975-11-28
PL96500B1 (en) 1977-12-31
AR206879A1 (en) 1976-08-31
DK137047B (en) 1978-01-09
JPS4945089A (en) 1974-04-27
EG10896A (en) 1976-07-31
AT327382B (en) 1976-01-26
JPS5318039B2 (en) 1978-06-13
IE37961L (en) 1974-02-02
LU68143A1 (en) 1974-02-11
ZA735236B (en) 1974-07-31
CH574447A5 (en) 1976-04-15
NO144831B (en) 1981-08-10
DE2338389A1 (en) 1974-02-28
RO68719A2 (en) 1980-08-15
IE37961B1 (en) 1977-11-23
YU208673A (en) 1982-02-25
FR2194415A1 (en) 1974-03-01
ATA680773A (en) 1975-04-15
IL42820A (en) 1977-06-30
PH12770A (en) 1979-08-17
AU5843373A (en) 1975-01-30
GB1418656A (en) 1975-12-24
BE803094A (en) 1974-02-01
YU36966B (en) 1984-08-31
FR2194415B1 (en) 1976-12-31
NL7310696A (en) 1974-02-05
ES417461A1 (en) 1976-03-01
NO144831C (en) 1981-11-18
CS168459B2 (en) 1976-06-29
AU472676B2 (en) 1976-06-03
CA1015355A (en) 1977-08-09
SU576944A3 (en) 1977-10-15
IL42820A0 (en) 1973-10-25
FI56840B (en) 1979-12-31
FI56840C (en) 1980-04-10
SU576945A3 (en) 1977-10-15

Similar Documents

Publication Publication Date Title
YU35581B (en) Process for obtaining substituted piperidine derivatives
BG25801A3 (en) A method of obtaining 7-beta-mean opening bracket 2-aryl-2-(eterified oximine)acetamine mean closing bracket-3-carbamoiloxymethyl-ceph-3-em-4-carbonic acid
BG32717A3 (en) Method for obtaining of n- organo- n- phosphonomethylglicine- n- oxides
EG11196A (en) Method of manufacturing closing device
CA998517A (en) Method of making a connection
CS186737B2 (en) Method of producing bis-/4-hydroxyphenyl/-alkanacids
BG25209A3 (en) A method of obtaining of substituted aroylphenylacetous acids
BG24817A3 (en) Method of obtaining esters of a-aminoacylcephalosporin
BG25206A3 (en) A method of obtaining d 1-15-deoxoprostaglandine-e bottom 1
CS182234B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
BG25798A3 (en) A method of obtaining 6-mean opening bracket alfa-(amidine-and imidoilamine-alkanoilamine)-aracylamine mean closing bracket-penicylane acids
BG24957A3 (en) A method of obtaining a 2315 antibiotic
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
EG11125A (en) A process for preparation of 2-alkoxy-5-alkylsulphonyl-benzoic acids
BG25795A3 (en) A method of obtaining 2-hydrazinebenzothiazoles
BG25791A3 (en) A method of obtaining carbomoyl sulphooxide compounds
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS189616B2 (en) Method of producing basic substituted derivatives of theophyline
IL42226A (en) A process for the preparation of eburnamonines
BG25655A3 (en) A method of obtaining saccharase inhibitors
BG24960A3 (en) A method of obtaining l-lysin through fermentation
ZA735891B (en) A method of forming collagen dispersions
BG24953A3 (en) A method of obtaining phthalasines derivatives
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols